Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Mild COVID-19 (Argentina)
NCT04463264Phase 3Unknown
- Sponsor
- Roemmers
- Start
- Jun 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in coronavirus disease 2019 (COVID-19), sponsored by Roemmers. Status: unknown.
02
Drugs
nitazoxanide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04463264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04463264.